212 filings
8-K
HBIO
Harvard Bioscience Inc.
3 Apr 24
Entry into a Material Definitive Agreement
8:01am
8-K
HBIO
Harvard Bioscience Inc.
26 Mar 24
Departure of Directors or Certain Officers
5:00pm
8-K
HBIO
Harvard Bioscience Inc.
7 Mar 24
Harvard Bioscience Announces Fourth Quarter 2023 Financial Results
7:00am
8-K
HBIO
Harvard Bioscience Inc.
5 Jan 24
Results of Operations and Financial Condition
5:01pm
8-K
HBIO
Harvard Bioscience Inc.
7 Nov 23
Harvard Bioscience Announces Third Quarter 2023 Financial Results
7:00am
8-K
vhnhsn s7i
8 Aug 23
Harvard Bioscience Announces Second Quarter 2023 Financial Results
9:05am
8-K
gnu a0xyxvibwxydgu
20 Jun 23
Harvard Bioscience Appoints Jennifer Cote as Chief Financial Officer
8:15am
8-K
uxoelb d1vc1o2xo
15 May 23
Submission of Matters to a Vote of Security Holders
4:16pm
8-K
008h16hdlh93jab6kgb
25 Apr 23
Harvard Bioscience Announces First Quarter 2023 Financial Results
8:00am
8-K
f3wexbsyis3z9a5
13 Mar 23
Other Events
5:28pm
8-K
afi2o mx9ujw6gybe
10 Mar 23
Departure of Directors or Certain Officers
8:00am
8-K
nffpmrpiyz23qw
9 Mar 23
Harvard Bioscience Announces Fourth Quarter 2022 Financial Results
7:00am
8-K
511v2zu prxrided3t6
19 Jan 23
Departure of Directors or Certain Officers
5:00pm
8-K/A
48z82
3 Jan 23
Departure of Directors or Certain Officers
8:45am
8-K
ippk0 jq7jmtrufbora
12 Dec 22
Harvard Bioscience Announces CFO Transition
8:31am
8-K
11mn8
8 Nov 22
Harvard Bioscience Announces Third Quarter 2022 Financial Results
4:02pm
8-K
ugb9rt0r9dpr hj
4 Aug 22
Harvard Bioscience Announces Second Quarter 2022 Financial Results
7:01am
8-K
3miv1vl4g za0zf3k6
17 May 22
Departure of Directors or Certain Officers
4:39pm
8-K
datjm2mt9
4 May 22
Harvard Bioscience Announces First Quarter 2022 Financial Results
7:01am
8-K
zevfadg2ap4gxozu 2z
28 Apr 22
Entry into a Material Definitive Agreement
12:00am